Русский
Outpatient physicians’ compliance with clinical practice guidelines for the prevention of recurrent myocardial infarction
Gerasimov A.A., Polibin R.V., Mindlina A.Ya.
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia
Materials and methods. A cross-sectional study was conducted in an outpatient clinic branch in Moscow. A total of 126 records of outpatients diagnosed with MI in the past 3 years (2012–2015) were analyzed. The compliance of drug therapy prescriptions with federal clinical practice guidelines was analyzed in patients with a history of recurrent MI developing 28 days after previous stroke and in those with no history of recurrent MIs.
Results. The morbidity and mortality from coronary heart disease and acute MI remain at a high level in the Russian Federation. In the past 6 years, the mortality from recurrent MI has been more than twice that from single MI. An analysis of drug therapy prescriptions for patients with MI established their inconsistency with clinical practice guidelines for the prevention of the disease, as well as the low-level diagnosis of recurrent MI. An inadequate frequency of evidence IA drug uses and a very low frequency of percutaneous coronary intervention were identified.
Conclusion. An inconsistency between invasive and drug therapy policies in the prevention of recurrent MI and a low-level diagnosis of the latter suggest that the outpatient physicians show a low compliance with the clinical practice guidelines for the prevention of MI.
Literature
1. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008; 25(5): 457–507. DOI: 10.1159/000131083 2. World Health Organization. WHO Mortality Database. Geneva, Switzerland: World Health Organization, Department of Health Statistics and Information Systems; 2015. http://www.who.int/healthinfo/mortality_data/en/ Просмотрено 25.09.2016. 3. Shilova A.S., Novikova N.A., Shchekochikhin D.Yu., Syrkin A.L. [Long-term outcomes in patients with st-segment elevation acute coronary syndrome in t he application of a pharmacoinvasive approach and primary percutaneous coronary intervention: results of a two-year follow-up in real clinical practice conditions]. Klinitsist 2015; 9(4): 22–7. (In Russ.). 4. [The Demograhic Yearbook of Russia. 2015]. Moscow: Federalnaya sluzhba gosudarstvennoy statistiki, 2015. (In Russ.). 5. Townsend N., Wilson L., Bhatnagar P., Wickramasinghe K., Rayner M., Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J. 2016; 37(42): 3232–45. 6. Clinical Practice Guidelines in Practice and Education. J. Gen. Intern. Med. 1997; 12(Suppl 2): 25–33. 7. Lohr K.N., Field M.J. A provisional instrument for assessing clinical practice guidelines. In: Field M.J., Lohr K.N. (eds.). Guidelines for clinical practice. From development to use. Washington D.C.: National Academy Press, 1992. 8. Boytsov S.A., Chuchalin A.G. [Russian guideline for prevention of chronic noncommunicable diseases]. Moscow: Ministry of Health of Russia, 2013. (In Russ.). 9. Aronov D.M. [Russian clinical guideline for rehabilitation and secondary prevention patients after acute myocardial infarction with ST-segment elevation of the electrocardiogram]. Moscow: Ministry of Health of Russia, 2014. (In Russ.). 10. O’Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., Ettinger S.M., Fang J.C. et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127(4):e362–425. DOI: 10.1161/ CIR.0b013e3182742cf6. 11. European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 2016; 37(29): 2315– 81. DOI: 10.1093/eurheartj/ehw106. 12. Steg P.G., James S.K., Atar D., Badano L.P.,Lundqvist C.B., Borger M.A. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2012; 33 (20): 2569–619. DOI: 10.1093/eurheartj/ehs215. 13. Bockeria L.A, Klyuchnikov I. V. [Coronary artery bypass graft after primary restoration of a coronary blood flow at a myocardial infarction]. Grudnaya i serdechno-sosudistaya khirurgiya. 2014; 56(1): 4–10 (In Russ.).
About the Autors
For correspondence:
Andrey A. Gerasimov, Postgraduate Studien, Departament of Epidemiology and Evidence-Based Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University)
Address: 8, Trubetskaya St., Build. 2, Moscow 119991, Russia
Telephone: +7(499) 248-69-70
Е-mail: prostohunter@list.ru
Information about the authors:
Roman V. Polibin – PhD, Associate Professor, Associate Professor, Department of Epidemiology and Evidence-Based Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University), Moscow, Russia; е-mail: polibin@bk.ru
Alla Ya. Mindlina – MD, Prof., Department of Epidemiology and Evidence-Based Medicine, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University), Moscow, Russia; е-mail: mindlina@mma.ru
Similar Articles
